The largest database of trusted experimental protocols

10 protocols using paav cag tdtomato

1

Plasmid Purification and AAV Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids for transfection were purified by using Qiagen's endotoxin-free HiSpeed Gigaprep kit (Qiagen) and quantified by spectrophotometry. The integrity of the cis plasmids and ITRs were confirmed by restriction digest and NGS. Complete reagent information is listed in Supplementary Table S5.
The following plasmids were used to prepare the rAAV described in this study; pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA (Addgene 20298, a gift of Karl Deisseroth, unpublished) AAV-Cre-GFP (Addgene 68544, a gift of Eric Nestler), AAV-EF1a-DIO-GCaMP6s-P2A-nls-dTomato (Addgene 51082, a gift of Jonathan Ting), AAV-FLEX-rev-ChR2(H134R)-mCherry (Addgene 18916, a gift from Scott Sternson), rAAV2-retro helper (Addgene 81070, a gift of Alla Karpova), pAAV-hSyn-DIO-hM3D(Gq)-mCherry (Addgene 44361, a gift of Bryan Roth), pAAV-hSyn-DIO-hM4D(Gi)-mCherry (Addgene 44362, a gift of Bryan Roth), pAAV-hSyn-hM3D(Gq)-mCherry (Addgene 50474, a gift of Bryan Roth, unpublished), pAAV-hSyn-EGFP(Addgene 50465, a gift of Bryan Roth, unpublished), pAAV-CAG-GFP (Addgene 37825, a gift from Edward Boyden, unpublished), pAAV-CAG-tdTomato (Addgene 59462, a gift of Edward Boyden, unpublished), and pUCmini-iCAP-PHP.eB (Addgene 103005, a gift of Viviana Gradinaru).15–20 (link)
+ Open protocol
+ Expand
2

Retrograde AAV Vector Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Retrograde Adeno-Associated Viral vectors [AAVrg; i.e., AAV-CAG-hChR2-H134R-tdTomato (Cat#: 28017-AAVrg) and pAAV-CAG-tdTomato (codon diversified) (Cat#: 59462-AAVrg)] that allow the expression of tdTomato (tdTom) and/or the light sensitive cation channel, channelrhodopsin-2 (ChR2), were obtained from Addgene, and used at a titer of ≥7 × 10^12 vg/mL.
+ Open protocol
+ Expand
3

Engineered Barcode Viral Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid pAAV-CAG-tdTomato (Addgene, #59462) was first modified by replacing tdTomato and WPRE with EGFP by T4 DNA Ligase mediated ligation. A 15 bp barcode sequence was then inserted after the stop codon of EGFP, linked by EcoRI restriction enzyme recognition site. Sequences barcode 0 representing the AI target, CTGCACCGACGCATT; barcode 1 (DMS target), GAAGGCACAGACTTT; barcode 2 (MD target), GTTGGCTGCAATCCA; barcode 3 (BLA target), AAGACGCCGTCGCAA; barcode 4 (LH target), TATTCGGAGGACGAC. Other barcode sequences used for IHC include barcode 10, AGCTATGCACGATCA; barcode 206, GCGTAAGTCTCCTTG; barcode 210, CCTGTATGCGTGGAG. Engineered viruses were produced by Gene Editing Core Facility, Center for Excellence in Brain Science and Intelligence Technology.
+ Open protocol
+ Expand
4

AAV-Mediated Cell Manipulation in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following constructs were used: pAAV-CAG-tdTomato (Addgene plasmid #59462) was used to generate AAV-PHP.S-CAG-tdTomato virus (Addgene); and pAAV-mCherry-flex-DTA (Addgene plasmid #58536) was used to generate AAV2/PHP.S-mCherry-flex-DTA virus (BCH viral core). For FGF18 overexpression, the coding sequence of Fgf18 (with HA tag) was cloned into the pAAV backbone. The plasmid was further used to generate AAV8-CAG-FGF18–3XHA virus (Welgen).
All AAV viruses were injected intradermally. Viral stock was diluted to a concentration of 1E12 gc/ml with saline (0.9% NaCl). 50 μl of the diluted virus was injected once intradermally. Dorsal skin was collected 6 days following injection of AAV-PHP.S-CAG-tdTomato, 10 days following AAV8-CAG-FGF18–3XHA injection, and 18 days following AAV2/PHP.S-mCherry-flex-DTA. For APM ablation, AAV2/PHP.S-mCherry-flex-DTA was injected as described above into Myh11-CreER mice.
+ Open protocol
+ Expand
5

Viral Construct Design and Packaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CreOn-FlpOff and FlpOn-CreOff ExBoX viral constructs were designed using ApE (https://jorgensen.biology.utah.edu/wayned/ape/) and Vector Builder (https://en.vectorbuilder.com/) free software. The plasmids were synthesized and assembled by Vector Builder. Plasmid DNA was purified using the Qiagen Maxi Prep kit (Qiagen Cat#10023). AAVs were also packaged by Vector Builder into AAV2/9. pENN.AAV.CamKII 0.4. Cre. SV40 (AAV5) (deposited by James M. Wilson; Addgene #105558; RRID:Addgene_105558), pAAV-CAG-TdTomato (AAV5) (deposited by Edward Boyden; Addgene #59462; RRID:Addgene_59462) and pCAG-FLEX-EGFP-WPRE (AAV9) (deposited by Hongkui Zeng; Addgene #51502;; RRID:Addgene_51502) were obtained from Addgene (Oh et al., 2014 (link)). rAAV5/AAV-EF1α-FlpO-WPRE and rAAV9/CAG-GFP were obtained from the UNC GTC Vector Core. pENN.AAV.hSyn.Cre.hGH was Addgene #105555 (RRID:Addgene_105555) deposited by James M. Wilson. All the ExBoX constructs designed for this study, along with the maps and sequences, have been deposited in Addgene. Addgene IDs of ExBoX plasmids can be found in Table S2.
+ Open protocol
+ Expand
6

Retrograde Transporter Delivery to Nucleus Accumbens and vBNST

Check if the same lab product or an alternative is used in the 5 most similar protocols
For histology experiments, C57Bl/6J mice (n=2 mice per sex) were anesthetized with isoflurane in O2 (4% induction and 1% maintenance, 2 L/min) and bilaterally microinjected with 500 nl (100 nL/min) of an AAV containing a green retrograde fluorescent transporter (pAAV-CAG-GFP; Addgene) into the Nucleus Accumbens (+1.6 AP, ± 1.5 ML, −4.4DV, mm relative to bregma, angle 10o) and 500 nl of a red retrograde fluorescent transporter (pAAV-CAG-tdTomato; Addgene) into to the vBNST (+0.16 AP, ± 0.9 ML, −4.8DV, mm relative to bregma). All subjects were perfused after 1 week.
For electrophysiology experiments, C57Bl/6J mice were anesthetized with isoflurane in O2 and injected with 500nl of pAAV-CAG-GFP into the vBNST for IC-cell body expression. The time from virus injection to the start of slice electrophysiology experiments was 2 weeks for all subjects.
+ Open protocol
+ Expand
7

Engineered AAV Capsid Variants for In Vivo Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The AAV capsid variants such as AAV-MaCPNS1 (Addgene plasmid # 185136) and AAV-MaCPNS2 (Addgene plasmid # 185137) capsids were built by inserting 7-mer peptides between AAs 588–589 of the AAV9 cap gene in the pUCmini-iCAP-PHP.B backbone ((Deverman et al. 2016 (link)), Addgene plasmid # 103002). The AAV-PHP.S capsid was described previously ((Chan et al. 2017 (link)), Addgene plasmid # 103006).
For in vivo validation of AAV capsids, we packaged the vectors with a single-stranded (ss) rAAV genome: pAAV:CAG-2xNLS-EGFP (Deverman et al. 2016 (link)) (available from Caltech CLOVER Center upon request, a similar version with 1xNLS is in Addgene, plasmid # 104061), pAAV:CAG-EGFP, pAAV:hSyn1-tdTomato (a gift from Hongkui Zeng, Addgene plasmid # 51506, (Oh et al. 2014 (link))), pAAV:CAG-tdTomato (a gift from Edward Boyden, Addgene plasmid # 59462), pAAV:hSyn-DIO-hM3D(Gq)-mCherry (a gift from Bryan Roth, Addgene plasmid # 44361, (Krashes et al. 2011 (link))). To make the pAAV:CAG-jGCaMP8s plasmid, jGCaMP8s was synthesized as a gBlocks Gene Fragment (IDT) based on the sequence in the plasmid pGP-AAV-CAG-FLEX-jGCaMP8s-WPRE (Addgene plasmid # 162380) and subcloned into the plasmid pAAV:CAG-EGFP by replacing the EGFP gene.
+ Open protocol
+ Expand
8

Expressing tdTomato in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
pSuper-venus vector was described previously.61 (link) pAAV-CAG-tdTomato was purchased from Addgene (Cambridge, MA, USA).
+ Open protocol
+ Expand
9

Diverse Viral Vectors for Neuroscience Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the following commercially available viruses: pGP-AAV-syn-FLEX-jGCaMP7s-WPRE (3.1×1013 GC/mL, Addgene, 104491-AAV9); pAAV-CaMKIIa-EGFP (2.1×1013 GC/mL, Addgene, 50469-AAV8); pAAV-CaMKIIa-hM4D(Gi)-mCherry (2.1×1013 GC/mL, Addgene, 50477-AAV8); AAV.CamKII.GCaMP6s.WPRE.SV40 (2.1×1013 GC/mL, Addgene, 107790-AAV9); pAAV-CAG-tdTomato (1.3×1013 GC/mL, Addgene, 59462-AAVrg); AAV9-hSyn-NE2h (2.37×1013 GC/mL, Vigene Biosciences, YL10074-AAV9); pENN.AAV.hSyn.Cre.WPRE.hGH (1.2×1013 GC/mL, Addgene, 105553-AAVrg); pAAV.synP.DIO.EGFP.WPRE.hGH (4.3×1013 GC/mL, Addgene, 100043-AAV9); pAAV-hSyn-DIO-hM4D(Gi)-mCherry (1.2×1013 GC/mL, Addgene, 44362-AAV5).
+ Open protocol
+ Expand
10

Antibody and Reagent Database for Neuroscience Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used in this study: C-FOS (Cell Signaling, #2250, Clone#9F6, rabbit, 1:500); GFP (Abcam, ab13970, chicken, 1:1000); RAGC (Cell Signaling, #5466, rabbit, 1:500); TIPRL (Abcam, #ab70795, rabbit, 1:500); SHANK2 (Cell Signaling, #12218, rabbit, 1:500); SYNPO (Acris, #BM5086P, rabbit, 0.1 μg/ml); PSD95 (Cell Signaling, #2507, rabbit, 1:1000); HSP90 serum (gift from Dr Chung Wang, IMB, Taiwan, rabbit, 1:2000)21 (link); p-mTOR (Cell Signaling, #2448, rabbit, 1:500); mTOR (Cell Signaling, #2972S, rabbit, 1:500); S6K (Cell Signaling, #2708S, rabbit, 1:500); p-S6K70 T389 (Cell Signaling, #9205S, rabbit, 1:500); 4EBP (Cell Signaling, #9644S, rabbit, 1:500). The following reagents were obtained commercially: ProHance (Gadolinium contrast agent, Bracco Diagnostics, #111181); Vectastain Elite ABC kit (Vector Labs, #PK-6102); C21 (Tocris, #6422); OCT (Tissue-TeK, 4583); ZnSO4 (Sigma-Aldrich, #Z0251); 30 ppm zinc diet (Research Diets, D19410B). AAV vectors used in this study were: pAAV-CamKII-hM3D(Gq)-mCherry (Addgene, #50476); pAAV-CamKII-hM4D(Gi)-mCherry (Addgene, #50477)22 (link); pAAV-CAG-tdTomato (Addgene, #59462).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!